Advertisement
Singapore markets open in 5 hours 3 minutes
  • Straits Times Index

    3,322.62
    +14.72 (+0.45%)
     
  • S&P 500

    5,265.33
    -41.68 (-0.79%)
     
  • Dow

    39,048.31
    -622.73 (-1.57%)
     
  • Nasdaq

    16,725.86
    -75.69 (-0.45%)
     
  • Bitcoin USD

    67,248.91
    -2,506.17 (-3.59%)
     
  • CMC Crypto 200

    1,466.03
    -36.63 (-2.44%)
     
  • FTSE 100

    8,339.23
    -31.10 (-0.37%)
     
  • Gold

    2,333.60
    -59.30 (-2.48%)
     
  • Crude Oil

    76.82
    -0.75 (-0.97%)
     
  • 10-Yr Bond

    4.4750
    +0.0410 (+0.92%)
     
  • Nikkei

    39,103.22
    +486.12 (+1.26%)
     
  • Hang Seng

    18,868.71
    -326.89 (-1.70%)
     
  • FTSE Bursa Malaysia

    1,629.18
    +7.09 (+0.44%)
     
  • Jakarta Composite Index

    7,222.38
    +36.34 (+0.51%)
     
  • PSE Index

    6,659.99
    +52.77 (+0.80%)
     

Medical Facilities First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Medical Facilities (TSE:DR) First Quarter 2024 Results

Key Financial Results

  • Revenue: US$108.3m (flat on 1Q 2023).

  • Net income: US$1.77m (down 60% from 1Q 2023).

  • Profit margin: 1.6% (down from 4.0% in 1Q 2023).

  • EPS: US$0.07 (down from US$0.17 in 1Q 2023).

earnings-and-revenue-growth
earnings-and-revenue-growth

All figures shown in the chart above are for the trailing 12 month (TTM) period

Medical Facilities Revenues Beat Expectations, EPS Falls Short

Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) missed analyst estimates by 73%.

Looking ahead, revenue is forecast to stay flat during the next 2 years compared to a 9.0% growth forecast for the Healthcare industry in Canada.

ADVERTISEMENT

Performance of the Canadian Healthcare industry.

The company's shares are up 1.4% from a week ago.

Risk Analysis

You should learn about the 1 warning sign we've spotted with Medical Facilities.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.